Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti-hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes.
O MontvidaJ B GreenJ AthertonSanjoy K PaulPublished in: Diabetic medicine : a journal of the British Diabetic Association (2018)
No significant differences in the risk of developing pancreatic diseases in those treated with various anti-hyperglycaemic drug classes were found.
Keyphrases